Business Wire10d
Epredia Receives U.S. FDA 510(K) Clearance for the E1000 Dx™ Digital Pathology Solution Designed to Improve Laboratory Workflow in Cancer Diagnostics
PORTSMOUTH, N.H. & KALAMAZOO, Mich.--(BUSINESS WIRE)--Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation (TSE: 6523), today announced U.S. Food and ...
Finanznachrichten9d
Epredia Receives U.S. FDA 510(K) Clearance for the E1000 Dx Digital Pathology Solution Designed to Improve Laboratory Workflow in Cancer Diagnostics
Innovative technology digitizes up to 1,500 tissue samples daily, supporting quick and accurate diagnosis by pathologists Epredia, a global leader in precision cancer diagnostics and subsidiary of ...